MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Medicine Maker

  • September 29, 2026
How Companion Diagnostics Can Support Targeted Drug Launches
  • Jane Li
  • September 29, 2026
  • 6 min
  1. Precision medicine relies on the reliable delivery of diagnostics in routine practice to influence treatment decisions.
  2. Companion diagnostics identify patients likely to benefit from targeted therapies, but slow adoption can lead to suboptimal treatment.
  3. Community hospitals face significant barriers in implementing next-generation sequencing compared to academic centers, affecting patient access.
  4. Turnaround time for diagnostic results is critical; delays can prevent patients from receiving timely, matched therapies.
  5. Collaboration between pharmaceutical and diagnostics companies is essential for effective co-development and timely market access.
...more

World Journal Of Urology

  • September 29, 2026
Addressing the Accessibility Challenges of PSMA PET/CT in Prostate Cancer: Insights, Obstacles, and Implementation Priorities
  • J. Gómez Rivas
  • L. Fernández Hernández
  • L. Turpin
  • A. Peyrottes
  • M. Rouprêt
  • September 29, 2026

Objective: To examine the accessibility of PSMA PET/CT for prostate cancer management, focusing on implementation challenges and the need for timely access. App

...more

Bmc Medicine

  • September 29, 2026
Clarification on the Discussion Surrounding "Ultra-Processed Foods and Their Impact on Human Health: Key Arguments and Supporting Evidence
  • Leandro F. M. Rezende
  • Maria Laura da Costa Louzada
  • Euridice Martinez-Steele
  • Geoffrey Cannon
  • Renata B. Levy
  • Patricia C. Jaime
  • Carlos A. Monteiro
  • September 29, 2026

Objective: To address criticisms raised by Ibsen and colleagues regarding ultra-processed foods (UPFs) and their health effects. Approach: Criticism 1: UPFs are

...more
2 min

Bmc Cardiovascular Disorders

  • September 29, 2026
Evaluating the Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio for Predicting Outcomes in Coronary Artery Bypass Grafting: A Retrospective Cohort Analysis
  • Mohammed Ahmed Elgazzar
  • Basma Mohamed Hani
  • Abdelhamid Fathi Ali
  • Mahmoud Ahmed Elshafie
  • Ashraf Moustafa Elnahas
  • September 29, 2026

Objective: To evaluate the effectiveness of the Prognostic Nutritional Index (PNI) and Neutrophil-to-Lymphocyte Ratio (NLR) measured before surgery in predictin

...more

Sentara

  • September 28, 2026
Latest Updates in Clinical Trials and HF Management: ESC Congress 2026
  • September 28, 2026
  1. Dr. Amin Yehya presented updates on heart failure therapies at the 2026 European Society of Cardiology.
  2. The presentation included recent clinical trial results relevant to heart failure management.
  3. New therapeutic approaches for heart failure were highlighted during the discussion.
  4. The updates aim to inform healthcare professionals about advancements in heart failure treatment.
  5. The 2026 ESC Congress served as a platform for sharing the latest research findings in cardiology.
...more

MDSpire News

  • September 28, 2026
FDA approves new treatment for FOP
  • Kathryn Wighton
  • September 28, 2026
  • 2 min

Objective: To reduce total new heterotopic ossification volume in patients with fibrodysplasia ossificans progressiva. Approach: Study Design: A randomized, dou

...more

MDSpire News

  • September 28, 2026
FDA expands treatment in nephrotic syndrome
  • Kathryn Wighton
  • September 28, 2026
  • 2 min

Objective: To reduce the risk of relapse in adult and pediatric patients aged 2 years and older with frequently relapsing or steroid-dependent, childhood-onset,

...more

Kff Health News

  • September 28, 2026
Food safety finds a place among ‘kitchen-table’ political issues
  • Stephanie Armour
  • September 28, 2026
  • 10 min
  1. A massive foodborne outbreak this summer sickened nearly 20,000 people, raising concerns about the safety of the U.S. food supply.
  2. Democrats are leveraging food safety concerns to criticize Republicans, linking them to budget cuts affecting public health.
  3. Public confidence in government food safety oversight is low, with 94% of U.S. adults worried about food recalls.
  4. The number of food recalls has increased over the years, with a significant rise in Class I recalls that pose serious health risks.
  5. Experts caution that recall numbers can be misleading, emphasizing that the number of people sickened is a more accurate measure of food safety.
...more

Inside Dentistry

  • September 28, 2026
Solventum Names Parag Kachalia Global Clinical Evidence Director
  • News Staff
  • September 28, 2026
  • 1 min
  1. Solventum appointed Parag Kachalia, DDS, as global clinical evidence director for its digital dental solutions.
  2. Kachalia joined Solventum on September 15 and will focus on clinical evidence strategy.
  3. He has 25 years of experience in clinical practice, academia, and dental technology strategy.
  4. Kachalia previously served as head of clinical practice at Overjet and chief clinical officer of Seattle Study Club.
  5. He was also a tenured faculty member at the University of the Pacific, Arthur A. Dugoni School of Dentistry.
...more

MDSpire News

  • September 28, 2026
Computer vision could turn surgical video into actionable clinical data
  • Meg Barbor
  • September 28, 2026
  • 5 min

Objective: To explore how computer vision can extract actionable insights from surgical video, enhancing documentation and decision-making in surgery. Approach:

...more

MDSpire News

  • September 28, 2026
Lasers trigger pigmentation from past gold therapy
  • Andrea Surnit
  • September 28, 2026
  • 3 min

Objective: To report on two cases of laser-induced chrysiasis following gold salt therapy for rheumatoid arthritis and evaluate treatment options. Approach: Pat

...more
1 min

MDSpire News

  • September 28, 2026
Trends in alcohol-linked cancer mortality
  • Kathryn Wighton
  • September 28, 2026
  • 3 min

Objective: To analyze trends in alcohol-attributable cancer mortality in the United States from 1990 to 2023. Approach: Data Analysis: Investigators analyzed Gl

...more

MDSpire News

  • September 28, 2026
VA/DoD guideline broadens tobacco treatment
  • Andrea Surnit
  • September 28, 2026
  • 5 min

Objective: To provide updated clinical practice guidelines for tobacco and nicotine dependence treatment in military service members and veterans. Approach: Gui

...more
2 min

MDSpire News

  • September 28, 2026
ACS report: Lung cancer deaths plunge as survival doubles
  • Andrea Surnit
  • September 28, 2026
  • 6 min

Objective: To analyze trends in cancer incidence and mortality, with a focus on lung cancer outcomes in the U.S. Approach: Data Sources: Population-based cancer

...more

The Medicine Maker

  • September 28, 2026
Musings from The Power List: Renee Aguiar-Lucander
  • September 28, 2026
  • 4 min

Objective: To discuss insights and reflections on drug development and the pharmaceutical industry from the perspective of Renee Aguiar-Lucander, CEO of Hansa B

...more

The Medicine Maker

  • September 28, 2026
Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169
  • September 28, 2026
  • 3 min
  1. Vyriad has initiated a phase I trial of VV169, a lentiviral therapy for generating BCMA-targeted CAR T cells in patients with multiple myeloma.
  2. VV169 is administered intravenously and does not require prior collection or modification of patient T cells, unlike traditional CAR T therapies.
  3. The trial is open-label and nonrandomized, aiming to enroll up to 40 adults with relapsed or refractory multiple myeloma.
  4. Primary endpoints of the trial include adverse events, maximum tolerated dose, and selection of a recommended phase II dose.
  5. The study will assess the safety and efficacy of VV169, with primary completion expected by August 2027.
...more

The Pathologist

  • September 28, 2026
Out With the Old, In With the New
  • Helen Bristow
  • September 28, 2026
  • 10 min
  1. The Stockport NHS pathology department has upgraded its laboratory information management system (LIMS) after over three decades of using the old system.
  2. The previous LIMS, Telepath, was limited by physical servers and outdated software, making it difficult to meet modern reporting requirements.
  3. The new WinPath system allows for virtualization, improved communication with other systems, and a user-friendly interface for staff.
  4. Implementation of the new LIMS is being conducted in two phases, starting with microbiology and cellular pathology to manage risks effectively.
  5. The transition emphasizes ensuring accurate data transfer throughout the testing process to avoid critical errors in patient results.
...more

The Pathologist

  • September 28, 2026
CAP Revises Breast and GI Reporting
  • September 28, 2026
  • 3 min
  1. CAP updated 14 Cancer Protocols, including breast cancer biomarker reporting and gastrointestinal stromal tumor molecular testing.
  2. The revisions align pathology reporting with WHO classifications, AJCC guidance, and advancements in precision oncology.
  3. The Breast Biomarker Protocol now includes updated scoring criteria for estrogen receptor, progesterone receptor, and HER2.
  4. New accreditation requirements for malignant phyllodes tumors mandate the use of the CAP Breast Phyllodes Tumor protocol.
  5. GIST protocols expanded to include NTRK fusion gene analysis and enhanced documentation for KIT and PDGFRA testing.
...more